Dumb question, maybe...sorry. Could Anavex get provisional approval based on the data through 148 weeks plus, once we get the peer reviewed publication? could that combination be enough for provisional "conditional" approval pending the results of P2/3 study? im asking if its possible, not probable. We would have more than 3years of data on a small sample size, which has been vetted as statistically significant when we get our peer review. Then we have our MOA to add support.
Thougths?